Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Krai, Chatamra"'
Autor:
Miho Murata, Masahito Mihara, Kazuko Hasegawa, Beomseok Jeon, Chon-Haw Tsai, Noriko Nishikawa, Tomoko Oeda, Masayuki Yokoyama, Weining Z. Robieson, Krai Chatamra, Maurizio F. Facheris, Janet Benesh
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 11 (2018)
Objectives: Levodopa-carbidopa intestinal gel (LCIG) was developed to reduce motor complications in Parkinson’s disease (PD) caused by pulsatile levodopa plasma concentrations following oral levodopa administration. Dyskinesia and ‘wearing off’
Externí odkaz:
https://doaj.org/article/f2b425b4f7d24f548b32e1f105db7879
Autor:
James T. Boyd, Hubert H. Fernandez, Maurizio Facheris, Ramon L. Rodriguez, Coleen Hall, Alberto J. Espay, Cindy Zadikoff, John T. Slevin, Krai Chatamra, Victor S.C. Fung, Susan Eaton, Weining Z. Robieson, Arvydas Vanagunas, Mark F. Lew, David G. Standaert, Janet Benesh
Publikováno v:
Movement Disorders. 33:928-936
BACKGROUND Levodopa-carbidopa intestinal gel (designated as carbidopa-levodopa enteral suspension in the United States) provides stable plasma levodopa concentrations and reduces motor fluctuations in advanced Parkinson's disease patients through con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::98fccf8509299cf1a83a241c1f35e54b
https://doi.org/10.1002/mds.27338
https://doi.org/10.1002/mds.27338
Publikováno v:
Journal of Parkinson's Disease
In a double-blind, double-dummy, double-titration Phase 3 trial in advanced Parkinson's disease (PD) patients, the efficacy and safety of Levodopa-carbidopa intestinal gel (LCIG) infusion were characterized relative to immediate-release oral levodopa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1407bdefd1b2e4999207bcce8c87c195
http://europepmc.org/articles/PMC5438475
http://europepmc.org/articles/PMC5438475
Autor:
John T. Slevin, David A. Stein, James T. Boyd, Jordan Dubow, Cindy Zadikoff, Ramon L. Rodriguez, Nathan Schmulewitz, Weining Z. Robieson, Susan Eaton, Per Odin, Victor S.C. Fung, Fabian Klostermann, Mark F. Lew, Janet Benesh, Hubert H. Fernandez, Alfonso Fasano, Peter V. Draganov, Sylvain Chouinard, Alberto J. Espay, Krai Chatamra, Anthony E. Lang
Publikováno v:
Movement Disorders
Background Continuous administration of levodopa‐carbidopa intestinal gel (carbidopa‐levodopa enteral suspension) through a percutaneous endoscopic gastrojejunostomy is a treatment option for advanced Parkinson disease (PD) patients with motor fl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4dd33cffd154b1c6921bb3c09cd44558
http://europepmc.org/articles/PMC5064722
http://europepmc.org/articles/PMC5064722
Autor:
Jordan Dubow, Rejko Krüger, John T. Slevin, Juan Carlos Martínez Castrillo, Janet Benesh, Krai Chatamra, Victor S.C. Fung, Mark F. Lew, Weining Z. Robieson
Publikováno v:
Parkinsonism & Related Disorders. 21(7):742-748
Background Levodopa-carbidopa intestinal gel (LCIG) provides continuous infusion and reduces “off” time in advanced Parkinson's disease (PD) patients with motor fluctuations despite optimized pharmacotherapy. Methods Clinical experience with 2 LC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a160f25ee6a8362216d5a387c4e4851d
Autor:
Cindy Zadikoff, John T. Slevin, Jordan Dubow, Coleen Hall, Krai Chatamra, Hubert H. Fernandez, Susan Eaton, Janet Benesh
Publikováno v:
Journal of Parkinson's Disease. 5:165-174
BACKGROUND Levodopa-carbidopa intestinal gel (LCIG) is delivered continuously via intrajejunal percutaneous gastrostomy tube. OBJECTIVE To examine long-term safety, efficacy and quality of life of LCIG in an open-label extension study. METHODS Patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bf38cb717358e8be2ab8ed40750a53d
https://doi.org/10.3233/jpd-140456
https://doi.org/10.3233/jpd-140456
Autor:
Thomas Nisslein, Chaim Ismail, Christian Conradt, Dianlin Guo, Frank Andersohn, Krai Chatamra, Anca Miclea
Publikováno v:
Journal of Parkinson's Disease
Background The independent contribution of levodopa exposure and Parkinson's disease (PD) to the risk of polyneuropathy is not established. Objective This study investigated whether patients with newly diagnosed PD without previous exposure to antipa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88b47d7020f243d18e63d1b4fea3e4a9
https://pubmed.ncbi.nlm.nih.gov/29154292
https://pubmed.ncbi.nlm.nih.gov/29154292
Autor:
Hubert H, Fernandez, James T, Boyd, Victor S C, Fung, Mark F, Lew, Ramon L, Rodriguez, John T, Slevin, David G, Standaert, Cindy, Zadikoff, Arvydas D, Vanagunas, Krai, Chatamra, Susan, Eaton, Maurizio F, Facheris, Coleen, Hall, Weining Z, Robieson, Janet, Benesh, Alberto J, Espay
Publikováno v:
Movement disorders : official journal of the Movement Disorder Society. 33(6)
Levodopa-carbidopa intestinal gel (designated as carbidopa-levodopa enteral suspension in the United States) provides stable plasma levodopa concentrations and reduces motor fluctuations in advanced Parkinson's disease patients through continuous del
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::37d1bdb94037832941fd44a56e29636a
https://pubmed.ncbi.nlm.nih.gov/29570853
https://pubmed.ncbi.nlm.nih.gov/29570853
Autor:
John T. Slevin, Coleen Hall, Janet Benesh, Ramon L. Rodriguez, Susan Eaton, David G. Standaert, Kavita Sail, Krai Chatamra, Yash J. Jalundhwala, Maurizio Facheris, Michael Lobatz
Publikováno v:
Movement Disorders Clinical Practice
Background Levodopa‐carbidopa intestinal gel (LCIG; carbidopa‐levodopa enteral suspension in the United States), delivered via percutaneous gastrojejunostomy (PEG‐J) and titrated in the inpatient setting, is an established treatment option for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::675110e076d5de83c015ac1ccb156cd5
https://pubmed.ncbi.nlm.nih.gov/29242809
https://pubmed.ncbi.nlm.nih.gov/29242809
Autor:
Per Odin, Eduard Z. Yakupov, Jordan Dubow, Fabian Klostermann, Janet Benesh, Mark F. Lew, Anthony E. Lang, Oksana Suchowersky, Victor S.C. Fung, Sylvain Chouinard, Hubert H. Fernandez, Weining Z. Robieson, David G. Standaert, Robert A. Hauser, Krai Chatamra, Coleen Hall, Alberto J. Espay, Malcolm Steiger
Publikováno v:
Movement Disorders
Motor complications in Parkinson's disease (PD) are associated with long-term oral levodopa treatment and linked to pulsatile dopaminergic stimulation. l-dopa-carbidopa intestinal gel (LCIG) is delivered continuously by percutaneous endoscopic gastro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbc320a67b4131860fc420f30a809dcf
http://europepmc.org/articles/PMC4674978
http://europepmc.org/articles/PMC4674978